Related Experiment Video
Updated: Jun 19, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Ebstein malformation of the tricuspid valve: current concepts in management and outcomes
Morgan L Brown1, Joseph A Dearani
1Joseph A. Dearani, MD Division of Cardiovascular Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. jdearani@mayo.edu.
Abstract:
Ebstein anomaly is a myopathy of the right ventricle that results in variable degrees of failure of delamination of the tricuspid valve leaflets from the underlying endocardium, leading to severe tricuspid valve regurgitation and some degree of right ventricular dysfunction. In neonates or infants who remain in congestive heart failure or profoundly cyanotic while receiving appropriate medical therapy, operation is required. Current strategies include biventricular or single-ventricle repair. In children and adults, medical management may be used, but most patients eventually require surgery. Tricuspid valve repair is preferred; we believe the cone repair is the most anatomic repair and is the operation of choice. Tricuspid valve replacement may be necessary in cases in which the valve is not repairable. A bidirectional cavopulmonary shunt is useful in patients with severe right ventricular dilatation and/or dysfunction. Transplantation rarely is necessary.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Endocarditis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse III: Nursing Management
